HBO Documentary Series, Vice, aired an episode on February 27th entitled, “Killing Cancer,” focusing on how different viruses are being used successfully as “weapons” to target cancer. The program focuses on 2013 ACGT Grantee Dr. John Bell, for his work … Read More
Dr. Lieping Chen, a founding member of the ACGT Scientific Advisory Council, is one of the very early pioneers in the field of pd-1 inhibitors, which has now led to the September, 2014 FDA approval of Keytruda for treating advanced melanoma. In … Read More
“Cancer is an aggressive disease for which the treatments often come with devastating side effects,” Margaret Cianci, Executive Director, Alliance for Cancer Gene Therapy said. “Cell and gene therapies, such as immunotherapy treatments for cancer, attack the cancer, not the … Read More
In 2012, Bob Levis, an Allentown, Pennsylvania resident, believed he had come to the end of his life. Diagnosed in 2002 with chronic lymphocytic leukemia, the cancer had resisted every possible treatment and had infiltrated his bone marrow, paralyzing his … Read More
“They took my cancer cells and irradiated them, and then injected them back into my body so my immune system would kick in,” Morrow said. Read More
I am an almost five year survivor of Stage IV NSCLC, adenocarcinoma. I attribute this amazing achievement to the grace of God, aggressive treatment and a “no stone left unturned” attitude. This attitude led me years ago to ACGT and the pioneering work of people like Dr. Jack Roth. Read More
ACGT is the nation’s only non-profit exclusively dedicated to gene and cell therapies for treating cancer. To date, ACGT has provided over $24 million in grants to top oncologists and funded breakthrough clinical trials that save lives. Learn more about ACGT … Read More
Dr. Michel Sadelain, ACGT Research Fellow, talks about the future of gene therapies for cancer treatment. When/Where: Alliance for Cancer Gene Therapy’s (ACGT) “Achieving Cancer Remission With Cell And Gene Therapies” held October 2013 at the Harvard Club in NYC. … Read More
Dr. Laurence Cooper, ACGT Research Fellow, emphasizes the need for philanthropy and private funding in the fight against cancer. . When/Where: Alliance for Cancer Gene Therapy’s (ACGT) “Achieving Cancer Remission With Cell And Gene Therapies” held October 2013 at the … Read More
The mission of ACGT is to seek out and support revolutionary scientific research into the causes, treatment and prevention of all types of cancer using cells and genes as medicine.
Cell and gene therapies are destroying tumors every day in the laboratory and in human trials, targeting only the cancer with few side effects to healthy tissue. ACGT’s rigorous grant review process, under the guidance of a preeminent Scientific Advisory Council, have resulted in some of the most successful breakthroughs in the history of cancer treatments and led to many patients in complete remission.
100% of our funding supports innovation and translational science that is proving again and again to offer better treatment options than the traditional therapies of chemotherapy, surgery and radiation. Every donation brings us closer to saving lives and changing the way we treat cancer forever.